• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

Introduction to (1R,2R)-2-fluorocyclopropanamine;hydrochloride (CAS No. 143062-85-5)

(1R,2R)-2-fluorocyclopropanamine;hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 143062-85-5, is a significant compound in the field of pharmaceutical chemistry. This compound has garnered attention due to its unique structural properties and potential applications in drug development. The presence of a fluorine atom in its structure and its chiral configuration make it a subject of intense research interest.

The< strong> fluorine-substituted cyclopropane ring in (1R,2R)-2-fluorocyclopropanamine;hydrochloride introduces unique electronic and steric effects that can influence its biological activity. Fluorine atoms are known to enhance metabolic stability, improve binding affinity, and modulate pharmacokinetic properties of molecules. This makes such compounds valuable scaffolds for designing novel therapeutic agents.

In recent years, there has been a surge in research focusing on fluorinated heterocycles due to their broad spectrum of biological activities. The< strong> cyclopropane moiety is particularly interesting because it introduces rigidity into the molecular structure, which can be exploited to optimize drug-like properties such as solubility, bioavailability, and target interaction.

One of the most compelling aspects of (1R,2R)-2-fluorocyclopropanamine;hydrochloride is its potential in the development of< strong> central nervous system (CNS) drugs. The combination of the fluorine atom and the cyclopropane ring can facilitate blood-brain barrier penetration, a critical factor for many CNS therapeutics. Preclinical studies have shown that fluorinated cyclopropanes can exhibit potent activity against various neurological disorders.

The< strong> hydrochloride salt form of this compound enhances its solubility in water, making it more suitable for formulation into injectable or oral medications. This form is particularly advantageous for drug delivery systems where solubility is a key determinant of efficacy.

Recent advancements in computational chemistry have enabled researchers to predict the binding modes of (1R,2R)-2-fluorocyclopropanamine;hydrochloride with various biological targets with high accuracy. These studies have revealed that the compound can interact with enzymes and receptors involved in pain signaling, inflammation, and neurodegeneration. This has opened up new avenues for developing treatments for conditions such as chronic pain, rheumatoid arthritis, and Alzheimer's disease.

The synthesis of (1R,2R)-2-fluorocyclopropanamine;hydrochloride involves complex organic transformations that require precise control over reaction conditions. The stereochemistry of the compound must be carefully maintained to ensure optimal biological activity. Researchers have developed innovative synthetic routes that utilize asymmetric catalysis to achieve high enantioselectivity, thereby producing the desired enantiomer in high yield.

In addition to its pharmaceutical applications, (1R,2R)-2-fluorocyclopropanamine;hydrochloride has shown promise in materials science. The unique structural features of this compound make it a candidate for developing novel polymers and coatings with enhanced mechanical properties and chemical resistance.

The< strong> future directions of research on (1R,2R)-2-fluorocyclopropanamine;hydrochloride are multifaceted. Scientists are exploring new synthetic methodologies to improve the efficiency and scalability of its production. Furthermore, preclinical and clinical trials are being conducted to evaluate its safety and efficacy in treating various diseases.

The integration of machine learning and artificial intelligence into drug discovery has accelerated the identification of promising candidates like (1R,2R)-2-fluorocyclopropanamine;hydrochloride. These technologies enable rapid screening of large chemical libraries and prediction of biological activity, thereby shortening the time required to bring new drugs to market.

In conclusion, (1R,2R)-2-fluorocyclopropanamine;hydrochloride is a versatile compound with significant potential in pharmaceuticals and materials science. Its unique structural features and biological activities make it a valuable tool for developing novel therapeutics targeting a wide range of diseases. As research continues to uncover new applications for this compound, its importance in science and medicine is likely to grow even further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)